Anne Wojcicki, the co-founder and former CEO of genetic data company 23andMe, has made headlines once again with her nonprofit organization, the TTAM Research Institute, winning a bidding war to acquire most of 23andMe’s assets for a hefty price of $305 million. This surprising turn of events comes shortly after biotech giant Regeneron had expressed interest in purchasing 23andMe for $256 million.
The acquisition agreement between TTAM Research Institute and 23andMe involved a final round of competitive bidding, ensuring that the best deal possible was secured for the company’s shareholders. This strategic move by the company’s board reflects a commitment to maximizing value and ensuring a smooth transition for 23andMe’s assets.
This latest development underscores Anne Wojcicki’s continued involvement in the genetic data industry, despite stepping down as CEO of 23andMe. Her leadership of the TTAM Research Institute signals a new chapter for the organization and its mission to advance research in the field of genetics.
While details of TTAM Research Institute’s plans for 23andMe’s assets remain undisclosed, the acquisition opens up possibilities for new avenues of research and innovation in the genetic data space. With Wojcicki at the helm, the nonprofit is poised to make significant contributions to the field and drive advancements in genetic research.
As the dust settles on this bidding war, the future looks bright for 23andMe under the stewardship of the TTAM Research Institute. With Anne Wojcicki leading the charge, the organization is well-positioned to make a lasting impact on the genetic data industry and pave the way for groundbreaking discoveries in the years to come.
